<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04845776</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00013694</org_study_id>
    <nct_id>NCT04845776</nct_id>
  </id_info>
  <brief_title>Vitamin/Mineral Supplement for Children With Autism</brief_title>
  <official_title>Vitamin/Mineral Supplement for Children With Autism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arizona State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Southwest College of Naturopathic Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Arizona State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an open-label 3 month clinical trial of a vitamin/mineral supplement designed for&#xD;
      children with autism.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an open-label 3 month clinical trial of a vitamin/mineral supplement designed for&#xD;
      children with autism. There will be pre/post assessments of autism symptoms,GI symptoms, and&#xD;
      laboratory tests. Typically-developing children will be assessed at baseline only (no&#xD;
      treatments) for comparison.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 4, 2021</start_date>
  <completion_date type="Anticipated">April 20, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 20, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All study participants with ASD will receive the vitamin/mineral supplement</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Parent Global Impressions of Autism</measure>
    <time_frame>assessed at the 3 months (end of treatment)</time_frame>
    <description>a 20-item questionnaire with a Likert scale assessing changes in symptoms</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Autism Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group receives the vitamin/mineral supplement, ANRC Essentials Plus, for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>ANRC Essentials Plus</intervention_name>
    <description>a vitamin/mineral supplement designed for children and adults with autism</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Child age 3-17 years (up until 18th birthday)&#xD;
&#xD;
          2. Previous diagnosis of ASD by a psychiatrist, psychologist, or developmental&#xD;
             pediatrician&#xD;
&#xD;
          3. Verification of diagnosis by ASU staff using the Autism Diagnostic Interview-Revised.&#xD;
&#xD;
          4. No changes in any medical, nutritional, dietary, behavior, or other treatment in the&#xD;
             last three months, and a willingness to avoid any changes during the study&#xD;
&#xD;
          5. Participant is able to wear a mask during the short visit for the blood draw.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Parent/guardian is unable to read or speak English fluently.&#xD;
&#xD;
          2. Use of a vitamin/mineral supplement in the past 3 months&#xD;
&#xD;
          3. Previous adverse reaction to a vitamin/mineral supplement&#xD;
&#xD;
          4. Unstable, poor health; seizure disorder that is not responsive to treatment or not on&#xD;
             stable management or complex type; or other health conditions that would significantly&#xD;
             increase their risk of adverse effects (per physician clinical judgement)&#xD;
&#xD;
          5. Use of any medication which has a contra-indication for one of the ingredients in the&#xD;
             vitamin/mineral supplement&#xD;
&#xD;
          6. A major single-gene disorder such as Fragile X, Down's Syndrome.&#xD;
&#xD;
          7. Major brain malformation&#xD;
&#xD;
          8. Tube feeding&#xD;
&#xD;
          9. Current participation in other clinical trials&#xD;
&#xD;
         10. Females who are pregnant or who are sexually active without effective birth control.&#xD;
&#xD;
         11. Clinically significant abnormalities at baseline on two blood safety tests:&#xD;
             Comprehensive Metabolic Panel and Complete Blood Count with Differential.&#xD;
&#xD;
         12. Psychotropic medication use which can affect neurotransmitter levels/function -&#xD;
             Current or within past 2 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James B Adams, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arizona State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>James B Adams, PhD</last_name>
    <phone>480 965 3316</phone>
    <email>jim.adams@asu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jasmine Kirby, MS</last_name>
    <phone>480 234 3767</phone>
    <email>jasykirby@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Arizona State University</name>
      <address>
        <city>Tempe</city>
        <state>Arizona</state>
        <zip>85287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jasmine Kirby, MS</last_name>
      <phone>480-234-3767</phone>
      <email>jasykirby@gmail.com</email>
    </contact>
    <investigator>
      <last_name>James B Adams, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://autism.asu.edu</url>
    <description>website for our research group</description>
  </link>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 12, 2021</study_first_submitted>
  <study_first_submitted_qc>April 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2021</study_first_posted>
  <last_update_submitted>May 5, 2021</last_update_submitted>
  <last_update_submitted_qc>May 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

